Biopharma cold chain logistics is the specialised process of storing, handling and transporting temperature sensitive medicines such as vaccines, biologics and cell therapies. The market is rapidly expanding, valued at about USD 30.59 billion in 2024 and projected to reach USD 74.46 billion by 2033 avec un 10.54 % taux de croissance annuel composé. Plus que 30 % of pharmaceutical products now require cold chain handling, and the demands of personalised therapies and stringent compliance deadlines make 2025 a pivotal year. This guide explains what cold chain logistics means for you, the challenges and innovations shaping the sector, initiatives de développement durable, regulatory updates and practical strategies to ensure product integrity.
What is biopharma cold chain logistics? – Definition, temperature ranges and why it matters in 2025.
What challenges will you face? – Rising costs, talent gaps, temperature excursions and compliance risks.
Quelles technologies transforment la chaîne du froid? – From IoT sensors and blockchain to predictive analytics and drones.
How is sustainability reshaping logistics? – Green storage, electrified fleets and reusable packaging.
What regulations and deadlines should you know? – DSCSA, EU FMD, WHO guidelines and GDP principles.
What market trends and opportunities are emerging? – Growth forecasts, regional insights and key players.
How to choose the right logistics partner? – Evaluation criteria and decision tools.
What is biopharma cold chain logistics and why does it matter?
Biopharma cold chain logistics refers to the integrated system of temperature controlled storage, packaging and transport required to move sensitive products like vaccines, biologique, blood products and cell & thérapies géniques. These products lose potency or become unsafe when exposed to incorrect temperaturesje. Regulatory agencies therefore mandate stringent storage and handling conditions, with common temperature ranges ranging from 2 °C à 8 °C for vaccines and insulin, below –20 °C for many biologics, and –80 °C to –150 °C for cell and gene therapies. Température ambiante contrôlée (15 °C à 25 °C) shipments also require monitoring because heat waves or cold snaps can push them outside specification.
The importance of cold chain logistics has grown with the expansion of biologics, monoclonal antibodies and gene therapies, which require ultra low temperatures. Rising patient demand and global vaccination campaigns amplify the need for reliable distribution networks. North America held the largest market share (38.33 %) dans 2024 thanks to its advanced infrastructure and regulatory framework, while Asia Pacific is the fastest growing region due to expanding pharmaceutical manufacturing and vaccine exports. Understanding how the cold chain works is the first step in protecting product efficacy and patient safety.
Temperature ranges and product categories
| Plage de température | Product examples | Ce que cela signifie pour vous |
| 2 °C – 8 °C (Réfrigéré) | Standard vaccines, insulin and GLP 1 agonists. Demand for GLP 1 drugs grew 300 % depuis 2023, straining refrigeration capacity. | Requires reliable coolers and short term storage; failure can cause potency loss and product recalls. |
| En dessous de –20 °C (Congelé) | Many biologics and speciality drugs requiring long term stability. | Needs power redundant freezers and packaging with phase change materials to maintain temperature for >120 heures. |
| –80 °C – –150 °C (Cryogenic) | Cell and gene therapies with viability windows under 72 heures; CAR T and mRNA therapies often shipped on dry ice. | Demands specialised containers and express networks; small fluctuations can destroy million dollar batches. |
| 15 °C – 25 °C (Controlled room) | Many small molecule drugs and diagnostic reagents. | Often overlooked; ambient shipments still need monitoring because temperature extremes can push them out of specification. |
Practical tips and user focused advice
Invest in calibrated monitoring – Use data loggers and IoT sensors that provide 15 second interval data with ±0.1 °C precision and GPS tracking. These devices alert you when temperatures drift and help prove compliance.
Match packaging to the product – Phase change materials and vacuum insulated panels can maintain the required range for more than 120 heures. For cryogenic shipments, consider portable cryogenic freezers that maintain –80 °C to –150 °C.
Planifier les imprévus – Build contingency plans for power outages or customs delaysje. Keep backup dry ice and reroute shipments when extreme weather threatens delivery.
Formez votre équipe – Ensure everyone handling shipments understands temperature requirements and emergency response protocolsje. Cross training can mitigate talent shortages and improve decision making.
Exemple du monde réel: A biotech firm shipping CAR T therapies used AI powered route optimisation and real time sensors. When a blizzard threatened delivery, the system rerouted the truck and alerted a backup driver. The therapy arrived within its 72 hour window, éviter une perte de plusieurs millions de dollars. This illustrates how proactive planning and technology can save lives and money.
What challenges will you face in 2025?
Despite rapid growth, the cold chain faces substantial headwinds. Rising costs, talent gaps and supply chain fragility threaten reliability. Par exemple, 63 % of manufacturers saw raw material costs increase by over 22 % depuis 2022, alors que 58 % of active ingredient suppliers are concentrated in three Asian countries. This concentration creates single point failure risks when geopolitical or climate disruptions occur. De plus, 40 % of companies report critical shortages in digital logistics and advanced therapy production roles, making it difficult to implement new technologies.
The financial stakes are high. Temperature excursions cause around USD 35 billion in annual losses and trigger a 12 % product recall rate. Even brief deviations can render a batch unusable. At transition nodes, products often sit in unrefrigerated airport zones or cross docking facilities, exposing biologics to ambient temperatures for hours. Monoclonal antibodies quickly lose efficacy when stored outside the 2 Plage °C–8 °C. These breaches often go undetected until after delivery because monitoring systems are fragmented across multiple third party logistics providers.
Cross border compliance adds further complexity. Region specific regulations such as the EU Good Distribution Practice (PIB) guidelines and the U.S. Loi sur la sécurité de la chaîne d'approvisionnement en médicaments (DSCSA) require serialization, traceability and comprehensive documentation. Companies must maintain different protocols for each region. Failure to comply can lead to customs delays, costly fines or product destruction. Last mile challenges also persist, especially in rural or coastal regions where infrastructure is weak, power is unreliable and temperature controlled storage is scarce.
Risk of temperature excursions and compliance gaps
| Défi | Description | Ce que cela signifie pour vous |
| Transition point excursions | Temperature excursions occur at handoff points like airports or warehouses, not during linehaul. Unrefrigerated holding zones and customs delays expose drugs to ambient temperatures. | Map every handoff and ensure time in transit is minimized. Utiliser 24/7 monitoring and choose partners with temperature controlled facilities. |
| Fragmented monitoring | Shipments pass through multiple 3PLs and ground handlers who use disconnected systems, making it hard to track temperature, humidity or handling times in real time. | Demand unified systems that share data across partners. Implement cloud based monitoring platforms and contract only GDP compliant providers. |
| Documentation errors | Even minor documentation gaps can trigger cross border delays. One shipment of oncology drugs was held for 48 hours because a temperature log was missing. | Automate documentation, validate transaction histories and train staff to avoid manual errors. |
| Infrastructure constraints | Rural and coastal areas lack cold storage capacity and reliable electricity, leading to frequent vaccine freezing or overheating. A WHO study found that 75 % of hepatitis B shipments in Indonesia experienced freezing during transit or local storage. | Use portable solar powered cold storage units and consider drones or mobile freezers to reach remote locations. |
Practical solutions to mitigate risk
Audit your routes: Identify every transfer point, measure dwell times and assess risk. Use AI powered route optimisation tools that factor in traffic and weather to minimize delays.
Invest in validated packaging: Choose phase change materials and vacuum insulated panels that maintain temperatures for extended periods.
Enhance training: Cross train staff and provide quick reference guides so any handler can respond to sensor alerts.
Numériser la documentation: Adopt systems that generate electronic transaction histories and real time serialization to meet DSCSA and FMD requirements.
Étude de cas: When an unexpected blizzard threatened a CAR T therapy shipment, AI route optimisation rerouted the truck and alerted a backup driver. The therapy arrived within its 72 hour viability window, demonstrating that predictive technology and contingency planning can prevent multimillion dollar losses.
Quelles technologies transforment la chaîne du froid?
Digital, autonomous and data driven innovations are reshaping cold chain logistics. Modern IoT sensors provide 15 second interval data with ±0.1 °C precision and combine GPS positioning. These devices, used during Pfizer’s COVID 19 vaccine rollout, enabled real time monitoring across air, route, ocean and rail transport. Blockchain technology creates a tamper proof digital ledger of every transaction, helping trace shipments and combat a USD 4.5 billion counterfeit drug market. Predictive analytics and AI forecast demand, anticipate disruptions and estimate shelf life, reducing cold chain waste by up to 28 %. Autonomous mobile units and refrigerated drones now complete around 30 % of metro area deliveries and operate in 12 pays. Quantum computing and digital twins optimise complex distribution networks in minutes, allowing planners to test scenarios and ensure Good Distribution Practice compliance.
Advanced packaging plays a critical role. 4D printed smart packaging uses shape memory polymers to self regulate temperature, while phase change materials maintain 2 °C–8 °C for over 120 heures. Portable cryogenic freezers hold –80 °C to –150 °C even in remote areas. Hyper automation uses robots for picking and packing, reducing errors and accelerating throughput. AI powered route optimisation computes the best delivery paths in real time, considering traffic, weather and road closures.
Technology and benefit matrix
| Technologie | Description | Bénéfice pour vous |
| Capteurs IoT & Suivi GPS | Devices monitor temperature, humidity and location every 15 seconds with ±0.1 °C precision. | Enhanced visibility; alerts you to deviations in real time, enabling intervention before product damage. |
| Chaîne de blocs | Distributed ledger records every transaction to prevent tampering and counterfeit drugs. | Simplifies audits and ensures traceability across suppliers and borders. |
| Analyse prédictive & IA | Algorithms forecast demand, predict disruptions and estimate shelf life, reducing waste by 28 %. | Optimised inventory and reduced spoilage; helps you plan manufacturing and logistics more accurately. |
| Autonomous units & drones | Self driving mobile freezers and drones handle last mile delivery. | Extend reach to remote areas, reduce human error and accelerate delivery. |
| Quantum computing & jumeaux numériques | Virtual replicas of the supply chain allow testing of scenarios and rapid optimisation. | Supports strategic planning and risk mitigation; helps you design resilient routes. |
| Emballage avancé | 4D printed and phase change materials maintain strict temperatures. | Ensures product integrity during long transits; reduces reliance on active cooling. |
| Hyper automation & Routage IA | Robots handle picking and packing; AI computes optimal routes. | Reduces labour costs, speeds up operations and lowers fuel consumption. |
Implementation tips
Start with sensors and dashboards: Begin by deploying IoT sensors and a cloud based dashboard for real time visibility. Visual alerts and automated reports simplify compliance.
Adopt blockchain pilots: Work with partners to pilot blockchain for high value shipments. Start with a small lane and evaluate the improvement in traceability.
Use AI for demand planning: Implement AI tools to forecast demand and shelf life. This reduces urgent shipments and ensures you have the right inventory at the right time.
Explore drones and mobile freezers: For remote deliveries, test autonomous refrigerated vehicles or drones. They can reach areas with poor infrastructure and ensure product integrity.
Leverage digital twins: Build a digital twin of your supply chain to simulate disruptions and optimise routes.
How is sustainability shaping the cold chain?
La durabilité n’est plus une option; regulators, investors and patients demand reduced carbon footprints. Healthcare activities account for 4.4 % of total global emissions, and the pharmaceutical sector generates 300 million tons of plastic waste annually. The EU Green Pharma Pact requires a 45 % reduction in cold chain carbon emissions by 2028. Governments and investors are also pushing companies toward net zero supply chains. Par conséquent, green logistics practices are accelerating.
Initiatives de durabilité & avantages
| Stratégie | Description | Bénéfice pour vous |
| Chambre froide à énergie solaire | Off grid units provide refrigeration in areas with unreliable grids. Southeast Asian sites cut energy bills using solar power, with commercial solar rates between 3.2 ¢ and 15.5 ¢ per kWh versus utility rates of 13.1 ¢. | Reduces operating costs and enables vaccine delivery in remote areas without consistent electricity. |
| Optimised routes & electrified fleets | Digital route planning minimizes fuel use; hybrid and electric vehicles reduce CO₂ output. | Lowers emissions and operating costs; improves compliance with environmental regulations. |
| Réutilisable & emballage biodégradable | Recyclable insulated containers, biodegradable thermal wraps and reusable cold packs cut waste. Biocair notes that not all routes can use reusable packaging because thermal performance must be maintained. | Reduces landfill waste and improves brand perception; requires careful route assessment to maintain performance. |
| Circular economy practices | Companies like Johnson & Johnson reuse packaging materials and recycle blister packs, vials and syringes. Cold Chain Technologies’ EcoFlex shipper reduces fossil fuel use by 60 % and greenhouse gas emissions by 48 %. | Diverts waste from landfills and reduces emissions; may require upfront investment in return logistics. |
| Surveillance numérique & inventory optimisation | Real time monitoring and analytics help right size inventories and reduce discards. | Minimizes expired or wasted drugs, réduire les coûts et l’impact environnemental. |
Regulatory pressure is also spurring sustainable practices. The net zero pharma supply chain market is growing due to sustainability mandates, investor demand and innovations such as AI driven logistics and renewable energy. Europe currently dominates this market, but Asia Pacific is expected to experience the fastest growth as China, India and Japan invest in green manufacturing and circular economy models. Recent innovations include SkyCell’s Net ZERO Reverse service, launched in March 2025, which eliminates the need to return containers by air and reduces CO₂ emissions by over 90 %.
Sustainability tips for businesses
Calculate your carbon footprint: Use online calculators or partner with logistics providers offering carbon tracking dashboards.
Choose renewable power: Power warehouses with solar or wind energy where possible.
Implement reusable packaging smartly: Assess route length and temperature requirements before selecting reusable containers.
Engage all partners: Collaborate across the supply chain to meet sustainability goals; success requires cooperation at every stage.
Optimise fleet utilisation: Combine shipments to reduce empty miles and coordinate returns to reuse packaging.
Exemple: A pharmaceutical distributor switched to optimized routing and reusable containers for insulin shipments. The company reduced repeat deliveries by 10 % and cut CO₂ emissions by approximately 20 %, demonstrating that sustainability can align with operational efficiency.
What regulations and compliance updates should you know?
Maintaining compliance is non negotiable in pharmaceutical logistics. Regulatory bodies such as the FDA, EMA and local authorities are tightening Good Distribution Practice (PIB) lignes directricesje. Compliance requires accurate temperature maintenance, 24/7 surveillance, validated infrastructure and detailed documentationje. Below are the core frameworks and deadlines you need to know for 2025.
Core cold chain compliance requirements
| Exigence | Explication | Action for you |
| Accurate temperature maintenance | Keep products within tightly controlled ranges (Par exemple, 2 °C–8 °C for refrigerated products, –20 °C for frozen, and –70 °C or lower for ultra low storage)je. | Equip your shipments with reliable refrigeration and phase change materials. Calibrate equipment regularly. |
| 24/7 surveillance | Deploy automated data loggers and real time systems to track temperature continuouslyje. | Use IoT sensors that provide continuous data and alerts. |
| Validated infrastructure | Use certified refrigeration units, transport containers and monitoring tools that consistently perform to required standardsje. | Choose partners with validated equipment and processes; request validation certificates. |
| Secure storage environments | Maintain controlled environments with restricted access and segregated storageje. | Audit warehouse security and ensure environmental controls. |
| Specialist packaging | Utiliser des expéditeurs isolés, phase change materials or gel packs to maintain temperatureje. | Select packaging based on product requirements and route length. |
| Detailed record keeping | Keep temperature logs, calibration records and training documentationje. | Implement digital systems for electronic records and audit trails. |
| Contingency plans | Prepare protocols for power loss, equipment failure and temperature excursionsje. | Develop emergency response SOPs and train staff accordingly. |
| Personnel formé | Ensure all personnel are trained in cold chain handling and emergency responseje. | Provide regular training, certifications and refresher courses. |
Key regulations and deadlines for 2025
Loi sur la sécurité de la chaîne d'approvisionnement en médicaments (DSCSA – United States): This law requires an interoperable electronic system to trace prescription drugs. After several delays, new staggered deadlines apply: manufacturers and repackagers must comply by 27 Peut 2025, grossistes par 27 Août 2025, and dispensers by 27 Novembre 2025.
EU Falsified Medicines Directive (FMD): Prescription medicines distributed within the European Union require unique identifiers and anti tampering devices. Manufacturers must register serial numbers in central databases, and pharmacies must verify products before dispensing.
WHO Model Guidance on Controlled Room Temperature: Updated in 2024, this guidance defines Good Distribution Practices for products stored between 15 °C et 25 °C.
ICH Q12 and Q13: These international guidelines harmonise post approval changes and Good Distribution Practices across regions.
Biosecure Act considerations: NOUS. federal funding restrictions may limit partnerships with certain foreign biotechnology companies. Diversify suppliers and monitor evolving legislation.
Compliance tips
Document everything: Use digital platforms to maintain chain of custody records, calibration data and training logsje.
Validate packaging and routes: Perform risk assessments and validation studies for new packaging and transportation routes.
Prepare for DSCSA audits: Build systems capable of producing electronic transaction information, history and statements upon request.
Rester informé: Subscribe to updates from the FDA, EMA et OMS. Regulations evolve quickly; early awareness lets you adapt ahead of deadlines.
What market trends and opportunities are shaping the next decade?
The biopharma cold chain logistics market is poised for significant growth. Grand View Research estimates the market size at USD 30.59 billion in 2024, projecting it to reach USD 74.46 billion by 2033 avec un 10.54 % TCAC. Polaris Market Research reports a 2024 market size of USD 18.23 billion for biopharma cold chain logistics and forecasts growth to USD 51.58 billion by 2034 avec un 10.98 % TCAC. The difference reflects differing methodologies but shows a clear upward trajectory. À propos 30 % of pharmaceutical products now require cold chain handling, driving expansion. Cold chain is the fastest growing segment within pharmaceutical logistics, expected to push the broader market to USD 208.3 billion by 2033.
Regional growth and key players
| Région | Growth characteristics | Key players & insights |
| Amérique du Nord | Largest market share (38.33 % dans 2024) thanks to advanced infrastructure and strict regulations. Significant investments in temperature controlled warehouses, IoT tracking and AI route optimisation. | Key companies include Cardinal Health, DHL Group, Agility, SF Express, Kinesis Medical, Hauts, Barrett Distribution, Cencora, DB Schenker and FedEx. UPS Healthcare announced expansion with 20 state of the art facilities in August 2025. |
| Europe | Growing market with strong GDP compliance and investments in cold storage facilities and last mile solutions. Brexit has increased complexities in cross border trade, making efficient cold chain management essential. | European Medicines Agency enforces strict guidelines, prompting real time monitoring and risk mitigation. Key players such as DHL, Kuehne + Nagel and UPS expand sustainable practices and blockchain integration. |
| Asie-Pacifique | Fastest growing region due to rising pharmaceutical manufacturing, vaccine exports and demand for biologics. Investments in temperature controlled warehouses and IoT tracking are increasing. | Chine, India and Japan are expanding cold chain infrastructure and tightening regulations. The region also leads in solar powered storage and drone deliveries. |
| l'Amérique latine & Middle East/Africa | Emerging markets with moderate adoption of IoT and blockchain and growing investment in cold storage capacity. | Infrastructure constraints persist; opportunities exist in portable cold storage and electrified fleets to reach remote populations. |
Investors and regulators are also driving decarbonization. The net zero pharma supply chain market is expanding due to sustainability mandates and investor pressure. Europe leads the market, while Asia Pacific shows the fastest growth. Technology adoption varies by region: North America excels in IoT and automated warehousing, Europe leads in blockchain integration, and Asia Pacific adopts high levels of automation.
Emerging trends for the next decade
Digital transformation: IA, IoT and big data analytics drive real time monitoring, predictive forecasting and dynamic routing. Companies will increasingly use AI based demand sensing to predict future needs based on epidemiological trends, seasonality and policy changes.
Advanced planning and risk management: Multi source purchasing and regional production centres will enhance resilience. Digital twins will allow scenario testing to pre empt disruptions.
Shift towards sustainability: Fleet electrification, biodegradable packaging and reusable containers will become standard. Regulators are imposing carbon reduction targets, encouraging solar powered storage and route optimisation.
Emerging delivery technologies: Autonomous vehicles and drones will handle last mile delivery. Portable cryogenic freezers and IoT connected containers will support ultra cold shipments.
Increased outsourcing and collaboration: Pharmaceutical companies will outsource more logistics to specialized 3PL providers, taking advantage of integrated end to end solutions. Partnerships across the supply chain will be crucial for sustainability and compliance.
Tips to leverage market opportunities
Investir dans la technologie: Adoptez les capteurs IoT, AI analytics and blockchain to improve visibility and efficiency.
Expand sustainability initiatives: Implement green storage and packaging solutions to meet regulatory mandates and appeal to eco conscious consumers.
Build regional resilience: Diversify suppliers and develop regional distribution hubs to mitigate geopolitical risks and reduce lead times.
Partner with trusted 3PLs: Select logistics providers with proven cold chain expertise, compliance certifications and advanced technology.
How can you choose the right biopharma cold chain logistics partner?
Selecting a logistics partner can make or break your product’s success. The right provider safeguards patient safety, meets regulatory requirements and supports your growth. Use the following criteria as a decision checklist.
Facteurs de décision & evaluation checklist
| Critère | Que chercher | Pourquoi ça compte |
| Conformité & attestations | Verify that the provider follows GDP and GMP standards, holds necessary licenses and passes audits. Ask for proof of DSCSA, FMD and WHO compliance. | Ensures products remain safe and that shipments avoid regulatory delays or finesje. |
| Technology capabilities | Look for IoT enabled tracking, real time dashboards, blockchain traceability and AI route optimisation. | Provides visibility, reduces risk of temperature excursions and streamlines documentation. |
| Sustainability commitments | Assess the provider’s use of green storage, electrified fleets, reusable packaging and carbon tracking tools. | Aligns with corporate ESG goals and emerging regulations; reduces carbon footprint. |
| Network coverage & infrastructure | Evaluate the size of the provider’s refrigerated fleet, warehouse capacity, and presence in key regions. | Ensures geographic reach, redundancy and the ability to handle ultra cold shipments. |
| Service reliability & customer support | Review on time delivery rates, temperature excursion records and customer reviews. Ask about contingency plans and 24/7 soutien. | Guarantees that emergencies are addressed promptly and reduces risk of product loss. |
| Experience with specialised therapies | Confirm experience handling cell and gene therapies, mRNA vaccines or other ultra cold products. | Ensures knowledge of strict temperature requirements and rapid delivery windows. |
Practical tips for partnering
Request a trial run: Start with a pilot shipment to evaluate tracking accuracy, temperature control and communication.
Conduct audits: Visit facilities to inspect equipment, calibration records and quality procedures.
Review data security: Ensure the provider has robust cybersecurity measures to protect sensitive data when using IoT or blockchain systems.
Negotiate service level agreements (SLAs): Define temperature ranges, acceptable excursion limits, response times and penalties.
Encourage collaboration: Foster open communication across your supply chain so partners can anticipate demand surges or regulatory changes.
2025 cold chain logistics FAQs
What are the DSCSA deadlines in 2025?
Manufacturers and repackagers must comply with the Drug Supply Chain Security Act by 27 Peut 2025. Wholesalers must comply by 27 Août 2025, and dispensers by 27 Novembre 2025.
How does IoT improve cold chain monitoring?
IoT sensors provide continuous temperature and location data with high precision. Real time alerts allow you to intervene before excursions occur, and the data logs support regulatory audits.
Why is sustainability important in biopharma logistics?
Healthcare activities contribute 4.4 % of global emissions and generate 300 million tons of plastic waste. Sustainable practices like solar storage, electrified fleets and reusable packaging reduce carbon footprints and meet regulatory expectations.
What is Good Distribution Practice (PIB)?
GDP comprises international standards that ensure medicines are stored and transported under appropriate conditions. Key principles include accurate temperature control, surveillance continue, validated infrastructure, secure storage, specialist packaging and meticulous documentation.
Why are phase change materials important?
Phase change materials maintain stable temperatures for extended periods, often over 120 heures. They reduce reliance on active cooling, making them ideal for remote shipments or supply disruptions.
Summary and actionable recommendations
Biopharma cold chain logistics is a critical enabler of modern medicine. Par 2025 the sector is forecast to grow rapidly, driven by rising demand for biologics and personalised therapies. Cependant, supply chain complexity, rising costs, talent shortages and regulatory pressure pose significant challenges. Innovations such as IoT sensors, blockchain, AI and advanced packaging are transforming how temperature sensitive products are tracked and transported. Sustainable practices—from solar powered storage to reusable packaging—are becoming mandatory. Compliance requirements like DSCSA, FMD and GDP demand meticulous monitoring, documentation et formation.
To thrive in this evolving landscape, invest in technology, adopt sustainable practices, construire regional resilience, et partner with reliable 3PL providers. Audit your routes, train your teams, and validate packaging and equipment. Embrace predictive analytics to anticipate disruptions, and use digital twins to plan contingencies. Enfin, stay informed about regulatory changes and collaborate with partners to meet carbon reduction targets. By taking these actions, you can ensure that life saving medicines reach patients safely and on time while supporting your organization’s growth and sustainability goals.
À propos du tempk
Tempk is a pioneering provider of temperature controlled packaging solutions for pharmaceuticals and life sciences. Notre R & D teams develop reusable and recyclable insulated boxes, phase change ice packs and vacuum insulated containers designed to maintain 0–10 °C or ultra low temperatures for extended periods. We are certified to Good Manufacturing Practice standards and constantly test our products to meet DSCSA, FMD and WHO guidelines. En mettant l’accent sur la durabilité, Tempk offers solar powered coolers and eco friendly materials to help customers cut carbon emissions and reduce packaging waste.
Étapes suivantes
Consult our experts: Contact Tempk for personalised guidance on selecting the right packaging and monitoring solutions.
Explore our products: Learn more about our insulated boxes, ice packs and reusable containers designed for pharmaceutical shipments.
Restez conforme: Let us help you navigate DSCSA, GDP and other regulatory requirements with validated packaging and digital monitoring systems.
